Transvaginal ultrasonographic measurement of endometrial thickness in postmenopausal women receiving estrogen replacement therapy

OBJECTIVE: This study was undertaken to evaluate endometrial thickness by transvaginal ultrasonography in asymptomatic postmenopausal women receiving estrogen replacement therapy. The endometrial thickness in this study group was compared with endometrial thickness measurements in a group of women w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 1997-06, Vol.176 (6), p.1334-1339
1. Verfasser: Holbert, Thomas R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1339
container_issue 6
container_start_page 1334
container_title American journal of obstetrics and gynecology
container_volume 176
creator Holbert, Thomas R.
description OBJECTIVE: This study was undertaken to evaluate endometrial thickness by transvaginal ultrasonography in asymptomatic postmenopausal women receiving estrogen replacement therapy. The endometrial thickness in this study group was compared with endometrial thickness measurements in a group of women who had abnormal postmenopausal bleeding. The recent literature was reviewed. STUDY DESIGN: Asymptomatic postmenopausal women receiving estrogen replacement, seen for routine examination during the 1-year period from Jan. 1, 1994, to Dec. 31, 1995, had the endometrium evaluated by transvaginal ultrasonography. Women with abnormal postmenopausal bleeding were likewise evaluated and their measurements compared with those of the study group. RESULTS: Twenty-seven different estrogen and estrogen-progestin combinations in 327 asymptomatic women were studied. Additionally, 24 women who were bleeding, not receiving estrogen, and 46 women with abnormal bleeding on estrogen therapy underwent ultrasonography of the endometrium. Endometrial thickness ranged from 1 to 15 mm in women on a regimen of combined estrogen-progestin therapy, 1 to 14 mm in women using sequential estrogen-progestin, and 3 to 15 mm for women receiving unopposed estrogen in the study group. For women with abnormal bleeding not using estrogen, the endometrium measured an average of 12.3 mm (range 2 to 29 mm), with unopposed estrogen 8.3 mm (range 4 to 13 mm), and for estrogen with progestin 6.5 mm (range 2 to 15 mm). Significant pathologic features were found in those women who had bleeding and endometrial measurements between 5.0 and 29 mm. CONCLUSION: There was no significant difference between endometrial thickness measurements in women receiving various combinations of estrogen replacement. In general, expected endometrial measurements can range from 1 to 15 mm. In women with postmenopausal bleeding, however, significant pathologic features may exist with an endometrium measuring as little as 5 mm. (Am J Obstet Gynecol 1997;176:1334-9.)
doi_str_mv 10.1016/S0002-9378(97)70354-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79111634</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002937897703545</els_id><sourcerecordid>79111634</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-71b89a2a89015fbb23d5f8010ef4f6c959532e0741273bc2ae56f95ee5e9f3153</originalsourceid><addsrcrecordid>eNqFkDlPxDAQhV2AuH_CSqkQFAEf62RdIYS4JCQKoLYcZ7xrSOxgO4so-ed4D9FSjTzvzbzxh9CE4AuCSXX5gjGmpWD17EzU5zVmfFryHXTw195HhzG-r55U0D20JyjhRLAD9PMalItLNbdOdcXYpaCid34e1LCwuuhBxTFADy4V3hTgWt9DCjZ7U9Y_HMRYWFcMPqZs8oMaY9a-sssVATTYpXXzAmIKfr5uDZ3Sm31pATnl-xjtGtVFONnWI_R2d_t681A-Pd8_3lw_lZpVOJU1aWZCUTUTmHDTNJS13MwwwWCmptKCC84o4HpKaM0aTRXwyggOwEEYRjg7QqebvUPwn2O-SPY2aug65cCPUdaCEFKxaTbyjVEHH2MAI4dgexW-JcFyhVuuccsVVylqucYtVwGTbcDY9ND-TW1ZZ_1qo0P-5dJCkFFbcBpam0kl2Xr7T8IvLuqVyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79111634</pqid></control><display><type>article</type><title>Transvaginal ultrasonographic measurement of endometrial thickness in postmenopausal women receiving estrogen replacement therapy</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Holbert, Thomas R.</creator><creatorcontrib>Holbert, Thomas R.</creatorcontrib><description>OBJECTIVE: This study was undertaken to evaluate endometrial thickness by transvaginal ultrasonography in asymptomatic postmenopausal women receiving estrogen replacement therapy. The endometrial thickness in this study group was compared with endometrial thickness measurements in a group of women who had abnormal postmenopausal bleeding. The recent literature was reviewed. STUDY DESIGN: Asymptomatic postmenopausal women receiving estrogen replacement, seen for routine examination during the 1-year period from Jan. 1, 1994, to Dec. 31, 1995, had the endometrium evaluated by transvaginal ultrasonography. Women with abnormal postmenopausal bleeding were likewise evaluated and their measurements compared with those of the study group. RESULTS: Twenty-seven different estrogen and estrogen-progestin combinations in 327 asymptomatic women were studied. Additionally, 24 women who were bleeding, not receiving estrogen, and 46 women with abnormal bleeding on estrogen therapy underwent ultrasonography of the endometrium. Endometrial thickness ranged from 1 to 15 mm in women on a regimen of combined estrogen-progestin therapy, 1 to 14 mm in women using sequential estrogen-progestin, and 3 to 15 mm for women receiving unopposed estrogen in the study group. For women with abnormal bleeding not using estrogen, the endometrium measured an average of 12.3 mm (range 2 to 29 mm), with unopposed estrogen 8.3 mm (range 4 to 13 mm), and for estrogen with progestin 6.5 mm (range 2 to 15 mm). Significant pathologic features were found in those women who had bleeding and endometrial measurements between 5.0 and 29 mm. CONCLUSION: There was no significant difference between endometrial thickness measurements in women receiving various combinations of estrogen replacement. In general, expected endometrial measurements can range from 1 to 15 mm. In women with postmenopausal bleeding, however, significant pathologic features may exist with an endometrium measuring as little as 5 mm. (Am J Obstet Gynecol 1997;176:1334-9.)</description><identifier>ISSN: 0002-9378</identifier><identifier>DOI: 10.1016/S0002-9378(97)70354-5</identifier><identifier>PMID: 9215193</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Aged ; Aged, 80 and over ; cancer ; Dose-Response Relationship, Drug ; Drug Therapy, Combination ; endometrium ; Endometrium - anatomy &amp; histology ; Endometrium - diagnostic imaging ; Endometrium - drug effects ; Estrogen Replacement Therapy - standards ; Estrogens - pharmacology ; Female ; Guidelines as Topic ; Humans ; Menorrhagia - physiopathology ; Middle Aged ; Postmenopause - physiology ; Progestins - pharmacology ; Transvaginal ultrasonography ; Ultrasonography</subject><ispartof>American journal of obstetrics and gynecology, 1997-06, Vol.176 (6), p.1334-1339</ispartof><rights>1997 Mosby, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-71b89a2a89015fbb23d5f8010ef4f6c959532e0741273bc2ae56f95ee5e9f3153</citedby><cites>FETCH-LOGICAL-c360t-71b89a2a89015fbb23d5f8010ef4f6c959532e0741273bc2ae56f95ee5e9f3153</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0002-9378(97)70354-5$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3541,27915,27916,45986</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9215193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Holbert, Thomas R.</creatorcontrib><title>Transvaginal ultrasonographic measurement of endometrial thickness in postmenopausal women receiving estrogen replacement therapy</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>OBJECTIVE: This study was undertaken to evaluate endometrial thickness by transvaginal ultrasonography in asymptomatic postmenopausal women receiving estrogen replacement therapy. The endometrial thickness in this study group was compared with endometrial thickness measurements in a group of women who had abnormal postmenopausal bleeding. The recent literature was reviewed. STUDY DESIGN: Asymptomatic postmenopausal women receiving estrogen replacement, seen for routine examination during the 1-year period from Jan. 1, 1994, to Dec. 31, 1995, had the endometrium evaluated by transvaginal ultrasonography. Women with abnormal postmenopausal bleeding were likewise evaluated and their measurements compared with those of the study group. RESULTS: Twenty-seven different estrogen and estrogen-progestin combinations in 327 asymptomatic women were studied. Additionally, 24 women who were bleeding, not receiving estrogen, and 46 women with abnormal bleeding on estrogen therapy underwent ultrasonography of the endometrium. Endometrial thickness ranged from 1 to 15 mm in women on a regimen of combined estrogen-progestin therapy, 1 to 14 mm in women using sequential estrogen-progestin, and 3 to 15 mm for women receiving unopposed estrogen in the study group. For women with abnormal bleeding not using estrogen, the endometrium measured an average of 12.3 mm (range 2 to 29 mm), with unopposed estrogen 8.3 mm (range 4 to 13 mm), and for estrogen with progestin 6.5 mm (range 2 to 15 mm). Significant pathologic features were found in those women who had bleeding and endometrial measurements between 5.0 and 29 mm. CONCLUSION: There was no significant difference between endometrial thickness measurements in women receiving various combinations of estrogen replacement. In general, expected endometrial measurements can range from 1 to 15 mm. In women with postmenopausal bleeding, however, significant pathologic features may exist with an endometrium measuring as little as 5 mm. (Am J Obstet Gynecol 1997;176:1334-9.)</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>cancer</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Therapy, Combination</subject><subject>endometrium</subject><subject>Endometrium - anatomy &amp; histology</subject><subject>Endometrium - diagnostic imaging</subject><subject>Endometrium - drug effects</subject><subject>Estrogen Replacement Therapy - standards</subject><subject>Estrogens - pharmacology</subject><subject>Female</subject><subject>Guidelines as Topic</subject><subject>Humans</subject><subject>Menorrhagia - physiopathology</subject><subject>Middle Aged</subject><subject>Postmenopause - physiology</subject><subject>Progestins - pharmacology</subject><subject>Transvaginal ultrasonography</subject><subject>Ultrasonography</subject><issn>0002-9378</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkDlPxDAQhV2AuH_CSqkQFAEf62RdIYS4JCQKoLYcZ7xrSOxgO4so-ed4D9FSjTzvzbzxh9CE4AuCSXX5gjGmpWD17EzU5zVmfFryHXTw195HhzG-r55U0D20JyjhRLAD9PMalItLNbdOdcXYpaCid34e1LCwuuhBxTFADy4V3hTgWt9DCjZ7U9Y_HMRYWFcMPqZs8oMaY9a-sssVATTYpXXzAmIKfr5uDZ3Sm31pATnl-xjtGtVFONnWI_R2d_t681A-Pd8_3lw_lZpVOJU1aWZCUTUTmHDTNJS13MwwwWCmptKCC84o4HpKaM0aTRXwyggOwEEYRjg7QqebvUPwn2O-SPY2aug65cCPUdaCEFKxaTbyjVEHH2MAI4dgexW-JcFyhVuuccsVVylqucYtVwGTbcDY9ND-TW1ZZ_1qo0P-5dJCkFFbcBpam0kl2Xr7T8IvLuqVyQ</recordid><startdate>19970601</startdate><enddate>19970601</enddate><creator>Holbert, Thomas R.</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19970601</creationdate><title>Transvaginal ultrasonographic measurement of endometrial thickness in postmenopausal women receiving estrogen replacement therapy</title><author>Holbert, Thomas R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-71b89a2a89015fbb23d5f8010ef4f6c959532e0741273bc2ae56f95ee5e9f3153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>cancer</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Therapy, Combination</topic><topic>endometrium</topic><topic>Endometrium - anatomy &amp; histology</topic><topic>Endometrium - diagnostic imaging</topic><topic>Endometrium - drug effects</topic><topic>Estrogen Replacement Therapy - standards</topic><topic>Estrogens - pharmacology</topic><topic>Female</topic><topic>Guidelines as Topic</topic><topic>Humans</topic><topic>Menorrhagia - physiopathology</topic><topic>Middle Aged</topic><topic>Postmenopause - physiology</topic><topic>Progestins - pharmacology</topic><topic>Transvaginal ultrasonography</topic><topic>Ultrasonography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Holbert, Thomas R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Holbert, Thomas R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transvaginal ultrasonographic measurement of endometrial thickness in postmenopausal women receiving estrogen replacement therapy</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>1997-06-01</date><risdate>1997</risdate><volume>176</volume><issue>6</issue><spage>1334</spage><epage>1339</epage><pages>1334-1339</pages><issn>0002-9378</issn><abstract>OBJECTIVE: This study was undertaken to evaluate endometrial thickness by transvaginal ultrasonography in asymptomatic postmenopausal women receiving estrogen replacement therapy. The endometrial thickness in this study group was compared with endometrial thickness measurements in a group of women who had abnormal postmenopausal bleeding. The recent literature was reviewed. STUDY DESIGN: Asymptomatic postmenopausal women receiving estrogen replacement, seen for routine examination during the 1-year period from Jan. 1, 1994, to Dec. 31, 1995, had the endometrium evaluated by transvaginal ultrasonography. Women with abnormal postmenopausal bleeding were likewise evaluated and their measurements compared with those of the study group. RESULTS: Twenty-seven different estrogen and estrogen-progestin combinations in 327 asymptomatic women were studied. Additionally, 24 women who were bleeding, not receiving estrogen, and 46 women with abnormal bleeding on estrogen therapy underwent ultrasonography of the endometrium. Endometrial thickness ranged from 1 to 15 mm in women on a regimen of combined estrogen-progestin therapy, 1 to 14 mm in women using sequential estrogen-progestin, and 3 to 15 mm for women receiving unopposed estrogen in the study group. For women with abnormal bleeding not using estrogen, the endometrium measured an average of 12.3 mm (range 2 to 29 mm), with unopposed estrogen 8.3 mm (range 4 to 13 mm), and for estrogen with progestin 6.5 mm (range 2 to 15 mm). Significant pathologic features were found in those women who had bleeding and endometrial measurements between 5.0 and 29 mm. CONCLUSION: There was no significant difference between endometrial thickness measurements in women receiving various combinations of estrogen replacement. In general, expected endometrial measurements can range from 1 to 15 mm. In women with postmenopausal bleeding, however, significant pathologic features may exist with an endometrium measuring as little as 5 mm. (Am J Obstet Gynecol 1997;176:1334-9.)</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>9215193</pmid><doi>10.1016/S0002-9378(97)70354-5</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 1997-06, Vol.176 (6), p.1334-1339
issn 0002-9378
language eng
recordid cdi_proquest_miscellaneous_79111634
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Aged
Aged, 80 and over
cancer
Dose-Response Relationship, Drug
Drug Therapy, Combination
endometrium
Endometrium - anatomy & histology
Endometrium - diagnostic imaging
Endometrium - drug effects
Estrogen Replacement Therapy - standards
Estrogens - pharmacology
Female
Guidelines as Topic
Humans
Menorrhagia - physiopathology
Middle Aged
Postmenopause - physiology
Progestins - pharmacology
Transvaginal ultrasonography
Ultrasonography
title Transvaginal ultrasonographic measurement of endometrial thickness in postmenopausal women receiving estrogen replacement therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T22%3A44%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transvaginal%20ultrasonographic%20measurement%20of%20endometrial%20thickness%20in%20postmenopausal%20women%20receiving%20estrogen%20replacement%20therapy&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Holbert,%20Thomas%20R.&rft.date=1997-06-01&rft.volume=176&rft.issue=6&rft.spage=1334&rft.epage=1339&rft.pages=1334-1339&rft.issn=0002-9378&rft_id=info:doi/10.1016/S0002-9378(97)70354-5&rft_dat=%3Cproquest_cross%3E79111634%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79111634&rft_id=info:pmid/9215193&rft_els_id=S0002937897703545&rfr_iscdi=true